Hospital Universitario Getafe   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Getafe Spain (1991)

Organization Overview

First Clinical Trial
2005
NCT01281748
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

FIB-Hospital Universitario de Getafe | Hospital Universitario de Getafe | Hospital Universitario Getafe

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conjunctivitis (Phase 2)

Hemorrhage (Phase 4)

Hypersensitivity (Phase 2)

Osteogenesis Imperfecta (Phase 1)

Peripheral Arterial Disease (Phase 4)

Peripheral Vascular Diseases (Phase 4)

Rhinitis (Phase 2)

Rhinitis, Allergic, Seasonal (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 10